ABULROB; Abedelnasser
Patent Applications and Registrations
Patent applications and USPTO patent grants for ABULROB; Abedelnasser.The latest application filed is for "anti-her3 antibody and uses thereof".
- ABULROB; Abedelnasser - Ottawa CA
- Abulrob; Abedelnasser - Orleans N/A CA
| Patent | Date |
|---|---|
| ANTI-HER3 Antibody and uses thereof App 20210246223 - ABULROB; Abedelnasser | 2021-08-12 |
| Formulations targeting IGFBP7 for diagnosis and therapy of cancer Grant 9,164,097 - Stanimirovic , et al. October 20, 2 | 2015-10-20 |
| Blood-brain Barrier Epitopes and Uses Thereof App 20150238637 - Abulrob; Abedelnasser ; et al. | 2015-08-27 |
| Compositions and methods for brain delivery of analgesic peptides Grant 8,986,689 - Stanimirovic , et al. March 24, 2 | 2015-03-24 |
| Anti-ICAM-1 single domain antibody and uses thereof Grant 8,623,369 - Abulrob , et al. January 7, 2 | 2014-01-07 |
| Anti-icam-1 Single Domain Antibody And Uses Thereof App 20130064763 - Abulrob; Abedelnasser ; et al. | 2013-03-14 |
| Compositions And Methods For Brain Delivery Of Analgesic Peptides App 20130034572 - Stanimirovic; Danica ; et al. | 2013-02-07 |
| Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer App 20120045391 - Stanimirovic; Daniva ; et al. | 2012-02-23 |
| Antibody-Targeted Carrier For Contrast Agents App 20110274617 - Abulrob; Abedelnasser ; et al. | 2011-11-10 |
| Blood-brain Barrier Epitopes And Uses Thereof App 20110097739 - Abulrob; Abedelnasser ; et al. | 2011-04-28 |
| Targeted Delivery of Compounds Using Multimerization Technology App 20090233357 - Abulrob; Abedelnasser ; et al. | 2009-09-17 |
| Blood-brain Barrier Epitopes And Uses Thereof App 20090047300 - Abulrob; Abedelnasser ; et al. | 2009-02-19 |
| Semiconductor Nanocrystals For Time Domain Optical Imaging App 20090020710 - Yu; Kui ; et al. | 2009-01-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 